EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
3.5.1.15 | dithiothreitol | enhances activity | Bos taurus | |
3.5.1.15 | NP-40 | enhances activity | Bos taurus | |
3.5.1.15 | Triton X-100 | increases activity of the enzyme | Bos taurus | |
3.5.1.15 | Tween-20 | enhances activity | Bos taurus |
EC Number | Application | Comment | Organism |
---|---|---|---|
3.5.1.15 | medicine | diagnosis of Canavan disease, an autosomal recessive neurodegenerative disorder characterized by aspartoacylase deficiency, technique for prenatal diagnosis | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.5.1.15 | Glycyl-L-aspartate | - |
Bos taurus | |
3.5.1.15 | N-carbobenzoxy-D-aspartic acid | - |
Bos taurus | |
3.5.1.15 | N-tert-butoxycarbonyl-D-aspartic acid-beta-benzyl ester | - |
Bos taurus |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.5.1.15 | 0.85 | - |
N-acyl-L-aspartic acid | - |
Bos taurus |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
3.5.1.15 | Ca2+ | stimulates activity 20-40% | Bos taurus | |
3.5.1.15 | Mg2+ | stimulates activity 20-40% | Bos taurus | |
3.5.1.15 | Mn2+ | stimulates activity 20-40%, above 0.1 mM inhibition | Bos taurus | |
3.5.1.15 | Zn2+ | stimulates activity 20-40%, above 0.1 mM inhibition | Bos taurus |
EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|---|
3.5.1.15 | 58000 | - |
SDS-PAGE | Bos taurus |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.5.1.15 | N-acetyl-L-aspartic acid + H2O | Homo sapiens | - |
acetate + aspartic acid | - |
? | |
3.5.1.15 | N-acetyl-L-aspartic acid + H2O | Bos taurus | - |
acetate + aspartic acid | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.5.1.15 | Bos taurus | - |
bovine | - |
3.5.1.15 | Homo sapiens | - |
human | - |
EC Number | Purification (Comment) | Organism |
---|---|---|
3.5.1.15 | - |
Bos taurus |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.5.1.15 | brain | - |
Homo sapiens | - |
3.5.1.15 | brain | - |
Bos taurus | - |
3.5.1.15 | skin fibroblast | - |
Homo sapiens | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
3.5.1.15 | 0.019 | 0.02 | - |
Bos taurus |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.5.1.15 | N-acetyl-L-aspartic acid + H2O | - |
Homo sapiens | acetate + aspartic acid | - |
? | |
3.5.1.15 | N-acetyl-L-aspartic acid + H2O | - |
Bos taurus | acetate + aspartic acid | - |
? | |
3.5.1.15 | N-acyl L-aspartic acid + H2O | - |
Homo sapiens | acetate + L-aspartate | - |
? | |
3.5.1.15 | N-acyl L-aspartic acid + H2O | - |
Bos taurus | acetate + L-aspartate | - |
? | |
3.5.1.15 | N-carbobenzoxy-L-aspartate + H2O | - |
Bos taurus | ? | - |
? | |
3.5.1.15 | N-tert-butoxycarbonyl-L-aspartic acid alpha-benzyl ester + H2O | - |
Bos taurus | ? | - |
? | |
3.5.1.15 | N-tert-butoxycarbonyl-L-aspartic acid beta-benzyl ester + H2O | - |
Bos taurus | ? | - |
? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
3.5.1.15 | monomer | 1 * 58000, SDS-PAGE, reducing conditions | Bos taurus |